In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum
- PMID: 22210439
- DOI: 10.1016/j.actatropica.2011.12.008
In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum
Abstract
Worldwide, 3 billion people are at risk of hookworm infection, particularly in resource-poor countries. While control of soil-transmitted helminthiases relies mostly on chemotherapy, only few drugs are available and concern about potential emergence of drug resistance is rising. In the present study, tribendimidine, a derivative of amidantel, and its metabolites deacylated amidantel (dADT) and acetylated deacylated amidantel (AdADT) were tested in vitro and in vivo against Heligmosomoides bakeri and Ancylostoma ceylanicum, two hookworm rodent models, alone or in combination with standard drugs. Tribendimidine achieved IC(50)s ≤ 5 μg/ml against both H. bakeri third-stage larvae and adults in vitro and a single 2 mg/kg oral dose resulted in complete worm elimination in vivo. Comparable results were obtained with dADT, whereas AdADT displayed no effect in vitro and gave a moderate worm burden reduction of 42.9% in H. bakeri-infected mice. Tribendimidine combined with albendazole, levamisole or ivermectin revealed antagonistic interactions against H. bakeri in vitro and no significant killing effect in vivo. Tribendimidine and dADT exerted high efficacies against A. ceylanicum third-stage larvae (IC(50)s < 0.5 μg/ml) whereas adults were moderately affected in vitro (IC(50)s > 88 μg/ml). In vivo at single oral doses of 10 mg/kg, dADT showed a slightly higher efficacy than tribendimidine, achieving worm burden reductions of 87.4% and 74.8%, respectively. At the same dose, AdADT reduced the worm burden by 57.9%. Synergistic interactions were observed with tribendimidine-levamisole combinations against A. ceylanicum in vitro (combination index at IC(50)=0.5), and in vivo (combination index at ED(90)=0.19). In conclusion, tribendimidine and dADT show potent anti-hookworm properties. The potential of the promising tribendimidine-levamisole combination should be investigated in greater detail.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
The effect of tribendimidine and its metabolites against Necator americanus in golden hamsters and Nippostrongylus braziliensis in rats.Parasitol Res. 2010 Mar;106(4):775-81. doi: 10.1007/s00436-010-1748-7. Epub 2010 Feb 13. Parasitol Res. 2010. PMID: 20155372
-
In vivo efficacy of the anthelmintic tribendimidine against the cestode Hymenolepis microstoma in a controlled laboratory trial.Acta Trop. 2012 Aug;123(2):78-84. doi: 10.1016/j.actatropica.2012.03.008. Epub 2012 Apr 1. Acta Trop. 2012. PMID: 22487754
-
The in vitro and in vivo effect of tribendimidine and its metabolites against Clonorchis sinensis.Parasitol Res. 2009 Nov;105(6):1497-507. doi: 10.1007/s00436-009-1579-6. Epub 2009 Aug 5. Parasitol Res. 2009. PMID: 19655171
-
Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations.Acta Trop. 2013 May;126(2):115-26. doi: 10.1016/j.actatropica.2013.01.009. Epub 2013 Jan 23. Acta Trop. 2013. PMID: 23352956 Review.
-
Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China.Acta Trop. 2005 Apr;94(1):1-14. doi: 10.1016/j.actatropica.2005.01.013. Acta Trop. 2005. PMID: 15777691 Review.
Cited by
-
Eugenol; Effective Anthelmintic Compound against Foodborne Parasite Trichinella spiralis Muscle Larvae and Adult.Pathogens. 2023 Jan 12;12(1):127. doi: 10.3390/pathogens12010127. Pathogens. 2023. PMID: 36678475 Free PMC article.
-
In vitro and in vivo anthelmintic and chemical studies of Cyperus rotundus L. extracts.BMC Complement Med Ther. 2023 Jan 19;23(1):15. doi: 10.1186/s12906-023-03839-7. BMC Complement Med Ther. 2023. PMID: 36658562 Free PMC article.
-
Improving eukaryotic genome annotation using single molecule mRNA sequencing.BMC Genomics. 2018 Mar 1;19(1):172. doi: 10.1186/s12864-018-4555-7. BMC Genomics. 2018. PMID: 29495964 Free PMC article.
-
In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasites.PLoS Negl Trop Dis. 2018 May 18;12(5):e0006506. doi: 10.1371/journal.pntd.0006506. eCollection 2018 May. PLoS Negl Trop Dis. 2018. PMID: 29775454 Free PMC article.
-
Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections.Antimicrob Agents Chemother. 2021 Jan 20;65(2):e00714-20. doi: 10.1128/AAC.00714-20. Print 2021 Jan 20. Antimicrob Agents Chemother. 2021. PMID: 33139276 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources